David Ewell Slade

USPTO Granted Patents = 8 (Patent Applications = 1)

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 31(Granted Patents)

Company Filing History:

Pharmacia & Upjohn Company

Years Active: 2010-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11904011 - North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof (2024-02-20),

2. 11351243 - North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof (2022-06-07),

3. 9987348 - PCV2B divergent vaccine composition and methods of use (2018-06-05),

4. 9566324 - North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof (2017-02-14),

5. 9102912 - Cellular permissivity factor for viruses and uses thereof (2015-08-11),

6. 8486685 - Cellular permissivity factor for viruses and uses thereof (2013-07-16),

7. 8058050 - Cellular permissivity factor for viruses and uses thereof (2011-11-15),

8. 7754464 - Cellular permissivity factor for viruses and uses thereof (2010-07-13),

Title: David Ewell Slade: Innovator in Veterinary Science

Introduction

David Ewell Slade is a prominent inventor based in Portage, MI (US), known for his significant contributions to veterinary science. He holds a total of 8 patents, showcasing his innovative approach to addressing critical issues in animal health.

Latest Patents

One of his latest patents focuses on the North American porcine reproductive and respiratory syndrome (PRRS) virus and its uses. This invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence for a genetically-modified North American PRRS virus. It includes methods to create related polypeptides, polynucleotides, and various components. Additionally, the patent covers vaccines that utilize the genetically modified virus and polynucleotides, along with a diagnostic kit designed to distinguish between naturally infected and vaccinated animals.

Career Highlights

Throughout his career, David has worked with notable companies such as Zoetis Services LLC and Pharmacia & Upjohn Company. His work in these organizations has significantly advanced the field of veterinary medicine, particularly in the development of vaccines and diagnostic tools.

Collaborations

David has collaborated with esteemed colleagues, including Jay Gregory Calvert and Siao-Kun Wan Welch, further enhancing the impact of his work in the industry.

Conclusion

David Ewell Slade's innovative contributions to veterinary science, particularly in the area of PRRS virus research, highlight his role as a leading inventor in the field. His patents and collaborations continue to influence advancements in animal health and diagnostics.

This text is generated by artificial intelligence and may not be accurate.